Parkman Healthcare Partners’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7M | Sell |
197,898
-62,523
| -24% | -$5.91M | 2.15% | 15 |
|
|
2025
Q1 | $16.5M | Sell |
260,421
-460,236
| -64% | -$29.2M | 1.96% | 17 |
|
|
2024
Q4 | $33.5M | Buy |
720,657
+94,205
| +15% | +$4.37M | 4.46% | 2 |
|
|
2024
Q3 | $18M | Buy |
626,452
+31,063
| +5% | +$894K | 2.3% | 10 |
|
|
2024
Q2 | $8.61M | Buy |
595,389
+65,869
| +12% | +$952K | 1.15% | 32 |
|
|
2024
Q1 | $8.52M | Buy |
529,520
+24,778
| +5% | +$399K | 1.05% | 35 |
|
|
2023
Q4 | $10M | Buy |
504,742
+86,809
| +21% | +$1.73M | 1.41% | 23 |
|
|
2023
Q3 | $6.81M | Buy |
417,933
+16,946
| +4% | +$276K | 1.25% | 27 |
|
|
2023
Q2 | $8.48M | Sell |
400,987
-87,008
| -18% | -$1.84M | 1.47% | 22 |
|
|
2023
Q1 | $9.8M | Buy |
487,995
+73,547
| +18% | +$1.48M | 2.13% | 14 |
|
|
2022
Q4 | $10.8M | Buy |
414,448
+91,175
| +28% | +$2.38M | 2.88% | 6 |
|
|
2022
Q3 | $3.3M | Buy |
+323,273
| New | +$3.3M | 0.94% | 38 |
|